An absolute indication for rapidly correcting anemia by RBC transfusion is:

Enhance your readiness for the MEDNAX Neonatal Nurse Practitioner Exam. Utilize flashcards, multiple-choice questions, and detailed explanations. Equip yourself for success!

Multiple Choice

An absolute indication for rapidly correcting anemia by RBC transfusion is:

Explanation:
Restoring tissue oxygenation is the primary goal of RBC transfusion in anemia. When red cell mass is low, arterial oxygen content falls, reducing oxygen delivery to tissues. Transfusing packed red blood cells increases hemoglobin concentration, boosting the oxygen-carrying capacity (CaO2) and thereby improving oxygen delivery (DO2) to organs. This is the key reason for rapid transfusion in anemic neonates who show signs of poor perfusion or hypoxia. Bilirubin-related issues are managed with phototherapy or exchange transfusion if needed, not as a direct reason to transfuse to fix anemia. Increasing white blood cell count isn’t a goal of RBC transfusion either. While donor blood contains hemoglobin A, the presence of HbA isn’t the indication for transfusion—the purpose is to raise the oxygen-carrying capacity to prevent tissue hypoxia.

Restoring tissue oxygenation is the primary goal of RBC transfusion in anemia. When red cell mass is low, arterial oxygen content falls, reducing oxygen delivery to tissues. Transfusing packed red blood cells increases hemoglobin concentration, boosting the oxygen-carrying capacity (CaO2) and thereby improving oxygen delivery (DO2) to organs. This is the key reason for rapid transfusion in anemic neonates who show signs of poor perfusion or hypoxia.

Bilirubin-related issues are managed with phototherapy or exchange transfusion if needed, not as a direct reason to transfuse to fix anemia. Increasing white blood cell count isn’t a goal of RBC transfusion either. While donor blood contains hemoglobin A, the presence of HbA isn’t the indication for transfusion—the purpose is to raise the oxygen-carrying capacity to prevent tissue hypoxia.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy